ArticleNature communications2025
Harnessing nitroarenes as nitrogen and oxygen sources for general oxo-aminomethylation of alkenes.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Amino alcohols are essential synthetic building blocks and privileged motifs in drug development, playing a crucial role in modulating pharmacokinetics and biological activity. However, the efficient synthesis of 3-amino alcohols remains challenging compared to their 2-amino counterparts, often requiring multistep procedures, expensive substrates, or highly sensitive reagents. Despite their versatile reactivity in advanced synthesis, nitroarenes remain underutilized as dual nitrogen and oxygen sources. Herein, we report a metallaphotoredox-catalyzed multicomponent oxo-aminomethylation of nitroarenes, tertiary alkylamines, and alkenes, providing a modular and cost-effective route to diverse 3-arylamino alcohols. This strategy features a broad substrate scope, excellent functional group tolerance, and high regioselectivity. The resulting amino alcohols serve as key intermediates for further derivatization, enhancing molecular complexity. By expanding the synthetic utility of nitroarenes, this method offers a practical and efficient pathway to bioactive molecules with pharmaceutical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.